Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application (Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, Others); Distribution Channel (Patients, Providers, Payers, and Employers) and Geography

  • THE3206879
  • 137 Pages
  • December 2018
  • Healthcare
Download Sample    Get Discount   
 
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The digital therapeutics market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. The growth of the digital therapeutics market is primarily attributed to the rising pressure on healthcare providers to reduce healthcare costs, rising prevalence of chronic diseases and rising in the number of partnerships and collaborations in the market are the major factors that anticipated to propel the growth for the digital therapeutics market in the forecast period. However, increasing rate of cyber threat and rise in data security issues are expected to act as major challenges hindering the market growth. On the other hand, large number of undiagnosed population is expected to be prevalent future trend in the global digital therapeutics market

Global digital therapeutics market segmented into by application and distribution channel. Based on application, the market is segmented into diabetes, cardiovascular disease, central nervous system disease, respiratory diseases, smoking cessation, musculoskeletal disease, and others. On the basis of distribution channel, the digital therapeutics market classified as patients, providers, payers and employers.

The diabetes segment anticipated to the fastest and largest growing segment in the forecast period. The body's inability to produce or effectively utilize the hormone insulin, caused diabetes. This inability prevents the body from adequately regulating blood glucose levels. Digital therapeutics help to monitor the blood glucose level of patients, which helps in reducing the prevalence of diabetes across the globe. The increasing prevalence of diabetes help to enhance the demand for digital therapeutics that majorly helps in increasing the growth of this market.

The patients segment is expected to be the largest and fastest growing segment in the coming years. The increasing prevalence of diabetes helps to drive the market. Moreover, rise in the number of cases of dementia and Alzheimer's disease also help to upsurge the demand for digital therapeutics in the forecast period.

The digital therapeutics market was estimated through extensive primary and secondary sources that includes a vast array of government authorized websites such as Centers for Disease Control and Prevention (CDC), Habib Medical Group (HMG), Indian Council Of Medical Research (ICMR), International Diabetes Federation (IDF), World Health Organization (WHO) and others. The primary respondents included chair-holders and representatives of the demand and supply side for healthcare industries as well as medical professionals at digital therapeutics device manufacturing companies, hospitals, and research centers.

TABLE OF CONTENTS

1. INTRODUCTION 18

1.1 SCOPE OF THE STUDY 18

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 18

2. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY TAKEAWAYS 19

3. GLOBAL DIGITAL THERAPEUTICS MARKET - MARKET LANDSCAPE 21

3.1 OVERVIEW 21

3.2 MARKET SEGMENTATION 21

3.2.1 Global Digital Therapeutics Market- By Application 22

3.2.2 Global Digital Therapeutics Market - By Distribution Channel 22

3.2.3 Global Digital Therapeutics Market - By Geography 23

3.3 PEST ANALYSIS 24

3.3.1 North America - PEST Analysis 24

3.3.2 Europe - PEST Analysis 26

3.3.3 Asia Pacific - PEST Analysis 28

3.3.4 Middle East and Africa (MEA) - PEST Analysis 30

3.3.5 South and Central America - PEST Analysis 32

4. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS 34

4.1 KEY MARKET DRIVERS 34

4.1.1 Rising Prevalence of Chronic Diseases 34

4.1.2 Rising Pressure on Healthcare Providers to Reduce Healthcare Costs 35

4.1.3 Rising in the Number of Partnerships and Collaborations in the Market 35

4.2 KEY MARKET RESTRAINTS 36

4.2.1 Cyber Threat and Rise in Data Security 36

4.3 KEY MARKET OPPORTUNITY 36

4.3.1 Large Number of Undiagnosed Population 36

4.4 FUTURE TREND 38

4.4.1 Increase in the Number of Start Ups 38

4.5 IMPACT ANALYSIS 39

5. DIGITAL THERAPEUTICS MARKET- GLOBAL ANALYSIS 40

5.1 GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN) 40

5.2 GLOBAL DIGITAL THERAPEUTICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 41

5.3 PROMINENT PLAYERS 42

5.4 PERFORMANCE OF KEY PLAYERS 42

5.4.1 Propeller Health 42

5.4.2 CANARY HEALTH 42

5.5 EXPERT OPINIONS 43

6. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS - BY APPLICATION 44

6.1 OVERVIEW 44

6.2 DIABETES MARKET 45

6.2.1 Overview 45

6.2.2 Global Diabetes Market Revenue and Forecasts to 2025 (US$ Mn) 45

6.3 CARDIOVASCULAR DISEASE MARKET 46

6.3.1 Overview 46

6.3.2 Global Cardiovascular Disease Market Revenue and Forecasts to 2025 (US$ Mn) 46

6.4 CENTRAL NERVOUS SYSTEM DISEASE MARKET 47

6.4.1 Overview 47

6.4.2 Global Central Nervous System Disease Market Revenue and Forecasts to 2025 (US$ Mn) 47

6.5 RESPIRATORY DISEASES MARKET 48

6.5.1 Overview 48

6.5.2 Global Respiratory Disease Market Revenue and Forecasts to 2025 (US$ Mn) 48

6.6 SMOKING CESSATION MARKET 49

6.6.1 Overview 49

6.6.2 Global Smoking Cessation Market Revenue and Forecasts to 2025 (US$ Mn) 49

6.7 MUSCULOSKELETAL DISEASE MARKET 50

6.7.1 Overview 50

6.7.2 Global Musculoskeletal Disease Market Revenue and Forecasts to 2025 (US$ Mn) 50

6.8 OTHER APPLICATIONS MARKET 51

6.8.1 Overview 51

6.8.2 Global Other Applications Market Revenue and Forecasts to 2025 (US$ Mn) 51

7. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS - BY DISTRIBUTION CHANNEL 52

7.1 OVERVIEW 52

7.2 PATIENTS MARKET 53

7.2.1 Overview 53

7.2.2 Global Patients Market Revenue and Forecasts to 2025 (US$ Mn) 53

7.3 PROVIDERS MARKET 54

7.3.1 Overview 54

7.3.2 Global Providers Market Revenue and Forecasts to 2025 (US$ Mn) 54

7.4 PAYERS MARKET 55

7.4.1 Overview 55

7.4.2 Global Payers Market Revenue and Forecasts to 2025 (US$ Mn) 55

7.5 EMPLOYERS MARKET 56

7.5.1 Overview 56

7.5.2 Global Employers Market Revenue and Forecasts to 2025 (US$ Mn) 56

8. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 57

8.1 OVERVIEW 57

8.2 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58

8.3 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN) 58

8.4 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY DISTRIBUTION CHANNEL (US$ MN) 59

8.5 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017-2025) (%) 59

8.6 US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60

8.6.1 US Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 61

8.6.2 US Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 61

8.6.3 US Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 62

8.7 CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63

8.7.1 Canada Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 64

8.7.2 Canada Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 64

8.7.3 Canada Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 65

8.8 MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66

8.8.1 Mexico Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 67

8.8.2 Mexico Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 67

8.8.3 Mexico Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 68

9. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 69

9.1 OVERVIEW 69

9.2 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70

9.3 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 70

9.4 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 71

9.5 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 71

9.6 GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72

9.6.1 Germany Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 73

9.6.2 Germany Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 73

9.6.3 Germany Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 74

9.7 UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75

9.7.1 UK Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 76

9.7.2 UK Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 76

9.7.3 UK Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 77

9.8 FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78

9.8.1 France Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 78

9.8.2 France Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 79

9.8.3 France Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 79

10. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 80

10.1 OVERVIEW 80

10.2 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81

10.3 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81

10.4 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 82

10.5 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 82

10.6 JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83

10.6.1 Japan Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 83

10.6.2 Japan Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84

10.6.3 Japan Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 84

10.7 CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85

10.7.1 China Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 86

10.7.2 China Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 86

10.7.3 China Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 87

10.8 INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88

10.8.1 India Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 89

10.8.2 India Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 89

10.8.3 India Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 90

11. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 91

11.1 OVERVIEW 91

11.2 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 92

11.3 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92

11.4 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 93

11.5 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 93

11.6 UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 94

11.6.1 UAE Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 94

11.6.2 UAE Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 95

11.6.3 UAE Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 95

11.7 SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 96

11.7.1 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 96

11.7.2 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 97

11.7.3 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 97

11.8 SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 98

11.8.1 South Africa Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 98

11.8.2 South Africa Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 99

11.8.3 South Africa Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 99

12. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 100

12.1 OVERVIEW 100

12.2 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101

12.3 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 101

12.4 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 102

12.5 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 102

12.6 BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103

12.6.1 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 104

12.6.2 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 104

12.6.3 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 105

12.6.4 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Pharmaceutical Service (US$ Mn) 105

13. DIGITAL THERAPEUTICS MARKET-KEY COMPANY PROFILES 106

13.1 PROPELLER HEALTH 106

13.1.1 Key Facts 106

13.1.2 Business Description 106

13.1.3 Financial Overview 107

13.1.4 Product/Services Portfolio 107

13.1.5 SWOT Analysis 107

13.1.6 Key Developments 107

13.2 CANARY HEALTH 109

13.2.1 Key Facts 109

13.2.2 Business Description 109

13.2.3 Financial Overview 109

13.2.4 Product/Service Portfolio 109

13.2.5 SWOT Analysis 110

13.2.6 Key Developments 110

13.3 NOOM, INC. 111

13.3.1 Key Facts 111

13.3.2 Business Description 111

13.3.3 Financial Overview 111

13.3.4 Product/Services Portfolio 111

13.3.5 SWOT Analysis 112

13.3.6 Key Developments 112

13.4 2MORROW INC. 113

13.4.1 Key Facts 113

13.4.2 Business Description 113

13.4.3 Financial Information 113

13.4.4 Product/Services Portfolio 113

13.4.5 SWOT Analysis 114

13.4.6 Key Developments 114

13.5 LIVONGO HEALTH 115

13.5.1 Key Facts 115

13.5.2 Business Description 115

13.5.3 Financial Information 115

13.5.4 Product/Service Portfolio 115

13.5.5 SWOT Analysis 116

13.5.6 Key Developments 116

13.6 PROTEUS DIGITAL HEALTH 118

13.6.1 Key Facts 118

13.6.2 Business Description 118

13.6.3 Financial Information 118

13.6.4 Product/Service Portfolio 118

13.6.5 SWOT Analysis 119

13.6.6 Key Developments 119

13.7 WELLDOC, INC 120

13.7.1 Key Facts 120

13.7.2 Business Description 120

13.7.3 Financial Overview 120

13.7.4 Product/Service Portfolio 120

13.7.5 SWOT Analysis 121

13.7.6 Key Developments 121

13.8 FITBIT, INC. 123

13.8.1 Key Facts 123

13.8.2 Business Description 123

13.8.3 Financial Overview 124

13.8.4 Product/Service Portfolio 124

13.8.5 SWOT Analysis 125

13.8.6 Key Developments 125

13.9 OMADA HEALTH, INC. 128

13.9.1 Key Facts 128

13.9.2 Business Description 128

13.9.3 Financial Overview 128

13.9.4 Product/Service Portfolio 128

13.9.5 SWOT Analysis 129

13.9.6 Key Developments 129

13.10 MANGO HEALTH 130

13.10.1 Key Facts 130

13.10.2 Business Description 130

13.10.3 Financial Overview 130

13.10.4 Product/Service Portfolio 130

13.10.5 SWOT Analysis 131

13.10.6 Key Developments 131

14. APPENDIX 132

14.1 ABOUT THE INSIGHT PARTNERS 132

14.2 GLOSSARY OF TERMS 132

14.3 METHODOLOGY 134

14.4 COVERAGE 135

14.5 SECONDARY RESEARCH 136

14.6 PRIMARY RESEARCH 136

LIST OF TABLES

TABLE 1. PROPORTION OF PEOPLE LIVING WITH DIABETES (20-79 YEARS) WHO ARE UNDIAGNOSED PER REGION, 2017 37

TABLE 2. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 58

TABLE 3. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 61

TABLE 4. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 62

TABLE 5. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64

TABLE 6. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 65

TABLE 7. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 67

TABLE 8. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 68

TABLE 9. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 70

TABLE 10. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 71

TABLE 11. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 73

TABLE 12. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 74

TABLE 13. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76

TABLE 14. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 77

TABLE 15. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79

TABLE 16. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 79

TABLE 17. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81

TABLE 18. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 82

TABLE 19. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84

TABLE 20. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 84

TABLE 21. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 86

TABLE 22. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 87

TABLE 23. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 89

TABLE 24. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 90

TABLE 25. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92

TABLE 26. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 93

TABLE 27. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 95

TABLE 28. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 95

TABLE 29. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97

TABLE 30. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 97

TABLE 31. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 99

TABLE 32. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 99

TABLE 33. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 101

TABLE 34. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 102

TABLE 35. BRAZIL DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104

TABLE 36. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 105

TABLE 37. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY PHARMACEUTICAL SERVICE (US$ MN) 105

TABLE 38. GLOSSARY OF TERMS, DIGITAL THERAPEUTICS MARKET 132

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 19

FIGURE 2. GLOBAL DIGITAL THERAPEUTICS MARKET BY APPLICATION, MARKET SHARE (%), 2017 20

FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, MARKET SHARE (%), 2017 20

FIGURE 4. DIGITAL THERAPEUTICS MARKET SEGMENTATION 21

FIGURE 5. DIGITAL THERAPEUTICS MARKET SEGMENTATION, BY REGION 22

FIGURE 6. NORTH AMERICA PEST ANALYSIS 24

FIGURE 7. EUROPE PEST ANALYSIS 26

FIGURE 8. ASIA PACIFIC PEST ANALYSIS 28

FIGURE 9. MIDDLE EAST AND AFRICA (MEA) PEST ANALYSIS 30

FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 32

FIGURE 11. DIGITAL THERAPEUTICS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 39

FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET- REVENUE FORECASTS AND ANALYSIS - 2017- 2025 (US$ MN) 40

FIGURE 13. GLOBAL DIGITAL THERAPEUTICS MARKET- BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 41

FIGURE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SHARES BY APPLICATION, 2017 & 2025 (%) 44

FIGURE 15. GLOBAL DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45

FIGURE 16. GLOBAL CARDIOVASCULAR DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46

FIGURE 17. GLOBAL CENTRAL NERVOUS SYSTEM DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47

FIGURE 18. GLOBAL RESPIRATORY DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48

FIGURE 19. GLOBAL SMOKING CESSATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49

FIGURE 20. GLOBAL MUSCULOSKELETAL DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50

FIGURE 21. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51

FIGURE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SHARES BY DISTRIBUTION CHANNEL, 2017 & 2025 (%) 52

FIGURE 23. GLOBAL PATIENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53

FIGURE 24. GLOBAL PROVIDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54

FIGURE 25. GLOBAL PAYERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55

FIGURE 26. GLOBAL EMPLOYERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56

FIGURE 27. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 57

FIGURE 28. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58

FIGURE 29. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017-2025) (%) 59

FIGURE 30. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61

FIGURE 31. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64

FIGURE 32. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67

FIGURE 33. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (%) 69

FIGURE 34. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70

FIGURE 35. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 71

FIGURE 36. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73

FIGURE 37. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76

FIGURE 38. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78

FIGURE 39. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017), (US$ MN) 80

FIGURE 40. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81

FIGURE 41. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 82

FIGURE 42. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83

FIGURE 43. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86

FIGURE 44. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89

FIGURE 45. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 91

FIGURE 46. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 92

FIGURE 47. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 93

FIGURE 48. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 94

FIGURE 49. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 96

FIGURE 50. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 98

FIGURE 51. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 100

FIGURE 52. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101

FIGURE 53. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 102

FIGURE 54. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research